Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.

Ravel-Chapuis A, Atieh SA, Fahmi C, Jasmin BJ

Open source

DOI
10.1016/j.jbc.2026.111219
Published
2026 Mar
Container
The Journal of biological chemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jbc.2026.111219,
  title = {Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.},
  author = {Ravel-Chapuis A and Atieh SA and Fahmi C and Jasmin BJ},
  year = {2026},
  journal = {The Journal of biological chemistry},
  doi = {10.1016/j.jbc.2026.111219},
  url = {https://doi.org/10.1016/j.jbc.2026.111219}
}

RIS

TY  - JOUR
TI  - Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.
AU  - Ravel-Chapuis A
AU  - Atieh SA
AU  - Fahmi C
AU  - Jasmin BJ
PY  - 2026
JO  - The Journal of biological chemistry
DO  - 10.1016/j.jbc.2026.111219
UR  - https://doi.org/10.1016/j.jbc.2026.111219
ER  - 

APA

A, R., SA, A., C, F., & BJ, J. (2026). Disruptions of cell signaling pathways in myotonic dystrophy type 1 skeletal muscle, their pathogenic impact, and potential for combinatorial therapeutics.. The Journal of biological chemistry. https://doi.org/10.1016/j.jbc.2026.111219

Source records